Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_537_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
86 Мб
Скачать
the pharmacological effect was established and expressed decreased satisfaction after reoccurrence of fine lines and wrinkles. Decreased duration of aesthetic augmentation is directly correlated with lower doses [148]. Additional research is indicated to determine the maximal value at which dosage increase no longer impacts the duration of wrinkle reduction [147] (Figs. 19 and 20).
Fig. 19 The posttreatment results are shown in a patient who received botulism toxin injections for correction of platysmal banding [150]
https://t.me/medicina_free
Fig. 20 Before (left) and after (right) photos of two patients who received neuromodulator therapy for masseteric hypertrophy. Improved facial contour is noted in the right images after treatment [149]
6 Injectable Fillers
Dermal fillers are well utilized in the improvement of skin contour and texture, reducing the appearance of fine lines and wrinkles while replacing
https://t.me/medicina_free
lost volume. There are various compositions of facial fillers with unique indications. Hyaluronic acid fillers are most frequently utilized in cosmetic augmentation, although other formulations include poly-Lactic acid, polymethyl-methacrylate microspheres (PMMA), polyalkymide, and calcium hydroxylapatite.
Depending on the composition, the results may disappear after 6months or last as long as 2–3years. Most people tolerate injectable fillers well with minimal side effects related to the normal physiological response, although complications have been well documented in the literature. As a rule of thumb, filler-related adverse effects tend to resolve once the filler is dissolved and processed [151, 152].
6.1 Filler Formulations
Various types of fillers are used for nonsurgical facial contouring and/or volume replacement, often characterized by their elastic modulus (G’). Fillers with a higher G’ tend to have increased cross-linking, allowing them to resist deformation (from applied pressure) and dynamic forces (from facial muscle use) with the additional advantages of increased volumizing and tissue support [153, 154].
Water absorption and cohesivity are additional factors to be considered when identifying the best formulation. Fillers with higher molecular cross­linking tend to have increased water absorption and are more cohesive after placement, allowing for improved tissue hydration and increased projection with volume replacement respectively. These characteristics can help injectors choose the best formulation, as the more water-absorbent fillers are well utilized in the lips but contraindicated in the tear trough [155].
Hyaluronic acid (HA) fillers are reversible and well utilized for many different injection sites, and as such are generally the most popular choice for both patients and injectors. Formulations with higher concentrations of HA allow for increased molecular cross-linking, thus increasing the G’ [156, 157]. Overall, the hydrating properties of HA, limited immunogenicity, and longer mechanism of action allow for tissue hydration in aging patients, improved safety, and maintenance of results even in mobile areas impacted by dynamic movement [158, 159].
Currently, the FDA-approved HA fillers include Juvéderm formulations (XC, VOLUMA, VOLBELLA, VOLLURE), Belotero Balance, Revanesse Versa, and the RHA collection (RHA 2, 3, and 4). Restylane was the first to
https://t.me/medicina_free
gain FDA approval in the United States and has incorporated XpresHAn technology into the newer Refyne and Defyne lines (2016), which allows for improved filler stability with dynamic facial expressions. Currently, FDA approval exists for Restylane Silk, Lyft, Refyne, Defyne, Kysse, and Contour formulations [160]. Juvederm has been approved since 2006 (Juvederm Ultra and Ultra Plus), well known for its high-water absorption and HA concentration (24mg/mL). Their new line updated the patented Hylacross technology with Vycross cross-linking, lending to reduced water absorption and cohesivity. Juvéderm VOLUMA is the second-line formulation with the highest G’ and well utilized in deeper injections, while the low cohesivity of VOLLURE is better suited to superficial filler placement [161, 162].
Belotero Balance (Merz Aesthetics, Greensboro, N.C.) fillers use cross­linked HA in addition to unlinked molecules, as part of their Cohesive Polydensified Matrix technology. The result is a smooth filler with increased cohesivity and low G’, and as such is best used for more superficial filler placement (intradermal or subdermal) [163165].
6.2 Indications and Contraindications
The underlying indication for most patients is facial rejuvenation, although the variable manifestations of aging impact some facial components more than others. These manifestations are listed in Table 4, along with the recommended injection site [166171].
Table 4 Various indications for filler augmentation are listed, along with the respective facial subunits which would benefit from injection with these indications
Presentation Injection site
Forehead rhytids Glabellar region
Loss of contour and/or sunken appearance of periorbital area and eyebrows
Periorbital region (upper and lower eyelids, infraorbital groove, root of nose-glabellar junction)
Tired appearance due to tear trough deformity and/or herniated orbital fat pads
Tear trough
Marionette lines and/or prejowl sulcus Lower jaw and lateral chin (below the lips)
Patients desiring correction of dorsal contour and/or increased nasal tip projection
Nasal dorsum (areas of concavity), nasal tip
Younger patients desiring improved lip volume
Central lips, cupid’s bow augmentation
https://t.me/medicina_free
Presentation Injection site
Older patients desiring improved lip volume and projection, vertical lip rhytids
Entire length of lips, increased volume laterally (displace vertical rhytids)
Bony resorption of the maxilla, concavity, and deep rhytids (nose to mouth corners)
Nasolabial folds
Less common indications include aesthetic correction of atrophic acne scars using HA, poly-L lactic acid, or collagen fillers, as well as improvement of chin contour after implant placement (when used concurrently with botulism toxin) [172174].
Contraindications are detailed below, with additional considerations for formulations, brands, and patient factors [175]:
Active infection at the injection site. Allergy/hypersensitivity to filler ingredient or lidocaine.
– Collagen and HA fillers with incorporated lidocaine are
contraindicated.
Current/previous history of glabellar necrosis. Immunosuppressive disease.
– May contraindicate use of poly-L-lactic acid.
6.3 Injection Technique
While there are specific indications for each target location, it is important to understand the general injection techniques. Isolated wrinkles or folds (e.g., nasolabial folds) are corrected with linear tunneling injection, in which the needle is inserted along the length of the wrinkle and filler is released carefully as the needle is withdrawn. Radial fanning uses multiple adjacent linear tunnels in a fan-like pattern when volume augmentation (e.g., malar augmentation) is indicated. Crosshatching is well suited for the marionette lines and prejowl sulcus and uses a grid of perpendicular and parallel filler tunnels. Serial puncture injection involves injection at multiple points in close proximity along the length of the wrinkle and can also be used to correct individual rhytids or folds [166].
For each specific region, there are indicated injection techniques, general recommended guidelines for filler formulation, and special considerations relevant to the local anatomy (Fig. 21).
https://t.me/medicina_free
Fig. 21 The image demonstrates the various injection depth for filler placement, which will be discussed in further detail in reference to specific areas of the face [176]
6.3.1 Temple
Hollowing of the temples may occur with aging, and the resulting concavity can be recontoured with fillers to produce a more youthful appearance. Injectors can inject superficially and subdermally to avoid the middle temporal vein and superficial temporal artery, which are, respectively, located in the temporal fat pad and temporoparietal fascia. While some providers prefer to avoid the underlying vasculature and remain superficial, others perform deeper injections keeping 2.5 cm above the zygomatic arch. Juvéderm VOLLURE is recommended for superficial injections such as temporal fillers, as well as blended Restylane-L (lidocaine) [177180].
6.3.2 Glabella
The superficial vasculature in the glabellar region, specifically supratrochlear and supraorbital vessels, are often a cause of complications in filler complications. The glabella is known as the riskiest injection site in regard to visual changes/loss. Filler injection is well suited to correct the
https://t.me/medicina_free
area just superior to the eyebrows where botulism toxin is contraindicated. In addition, formation of deep static wrinkles in this region can only be corrected with filler injection [181, 182].
The supratrochlear artery originates from the inner former of the eyebrow and branches up superficially to the anterior forehead, and the supraorbital artery is located a few centimeters laterally. Recently, surgeons have discussed use of the crest technique, which is performed by pinching the glabellar rhytids while the patient is frowning. Superficial projection of the rhytid allows for more precise superficial injection into the subreticular dermis while the vasculature is temporarily occluded. Superficial filler formulations are used, such as Belotero, Restalyne Refyne/Silk, and blended Juvederm (1:1 lidocaine composition), with a combined serial puncture and crosshatching technique [183, 184].
6.3.3 Cheek
Volume augmentation in the malar region is accomplished with radial fanning injections, placed deeply anterograde and retrograde just above the periosteum. Generally, fillers with a higher G’ value are chosen for this area due to the deep injection plane, including Juvéderm VOLUMA/VOLLURA or Restylane Defyne/Lyft. The lateral, medial, and anterior cheek should be targeted, while avoiding the infraorbital bundle (located about 1 fingerbreadth below the orbital rim) [182, 185].
6.3.4 Tear Trough
Thinner skin and racial variation make the tear through a complicated and unforgiving injection site, as any contour abnormalities will be highly visible. Injections are placed beneath the lower eyelid above the periosteum in a deeper plane, using a filler with lower G’ and minimal hydrophilic properties (Restylane Silk, Belotero, Juvéderm VOLLURE).
Smaller cannulae (30-guage) are used to place the filler, allowing for slower distribution of small aliquots. The linear threading technique can be utilized in which the needle is inserted towards the medial aspect, allowing for careful filler release upon lateral withdrawal. Undercorrection of the lateral tear trough should be avoided, while ensuring conservative medial or central augmentation [185187] (Fig. 22).
https://t.me/medicina_free
Fig. 22 The before (a) and after (b) images of a patient who received autologous fibroblast fillers for correction of an exaggerated tear trough [188]
6.3.5 Lips
Lip filler injections are commonly performed, and most injectors will refer to the ideal facial proportions when considering placement and volume. Generally, the vertical height from upper vermilion to lower vermilion can be divided into thirds, with the upper lip comprising the first and the lower lip contributing to the lower two-thirds. As shown in Fig. 24 (left), the inferior and superior labial arteries course horizontally through the deeper mucosa, indicating a maximal injection depth of 3 mm superficial to the vasculature [185, 189].
https://t.me/medicina_free
Rohrich et al. detail a five-step approach to lip augmentation, although the technique varies between injectors. The stepwise augmentation uses linear filling in the lateral upper and lower lips for primary oral commissure support and subsequent definition of the lip-skin junction and Cupid’s bow. Lateral aliquots of filler can then be placed superficially in the lower lip to add additional volume. Smaller, parenthesis-shaped areas of filler are placed from the height of the Cupid’s bow to the columella, allowing for philtral column definition [185].
6.3.6 Nasolabial Fold
Filler augmentation of the nasolabial fold is riskier than other sites, due to the superficial course of the facial artery in the upper fold and its anastomoses to inferior alar and lateral nasal arteries. Keeping this vasculature in mind, deeper injections are placed medial to the fold in the subdermal plane. The use of high G’ fillers such as Juvéderm VOLLURE, VOLUMA, or Restylane Lyft is documented in the literature [189191]. Similar improvements in the aesthetic appearance of nasolabial folds are observed with mid- to lateral cheek placement when compared with direct fold placement, highlighting the success of variable approaches [192] (Fig.
23).
https://t.me/medicina_free
Fig. 23 The yellow dots indicate lip filler placement, the orange dots highlight the placement of nasolabial filler injections, and the green dots indicate correct filler placement for treatment of marionette lines [193]
6.3.7 Nose (Liquid Rhinoplasty)
Liquid rhinoplasty is a temporary solution for the correction of a drooping nasal tip, dorsal hump, or minor nasal asymmetry. In some cases, liquid rhinoplasty is successful in aesthetic corrections post rhinoplasty and may be useful for correction when surgery is not an option [194].
There are multiple approaches to nasal contouring with fillers, although the increased vascularity along the side of the external lateral nasal walls limit the degree of injection-based augmentation. The angular arteries are located just lateral to the nose, with a vertical trajectory upward from the lips along the medial cheeks. Dorsal nasal arteries are vertically oriented along the sides of the dorsum, anastomosing with the horizontally oriented lateral nasal artery above the tip of the nose. Nasal vasculature is encountered between the SMAS (superficial musculoaponeurotic system) and cutaneous tissues, indicating deeper injection techniques to minimize damage or compression [190, 195].
Prior to injection, the skin should be carefully inspected for scarring and discoloration, which is a potential indicator of prior trauma and impaired vascular integrity. Hydrophilic fillers are generally contraindicated at the dorsum, and the use of Restylane-L (and other minimally hydrophilic formulations) prevents excess water absorption in the tissues. The needle is inserted at the dorsal midline in the deeper preperichondrial or preperiosteal planes to avoid the superficial vasculature, and filler is added as needed in regions of concavity to camouflage a nasal hump [185, 196] (Figs. 24 and
25).
https://t.me/medicina_free